Category:Pages with missing NCBI ID
From BugSigDB
When resolving issues shown on this page, please read and make notes on the Discussion page to avoid duplicating work. See https://en.wikipedia.org/wiki/Open_nomenclature for help with nomenclature conventions, and use the NCBI Taxonomy Browser. Also here is a 2-hour video of Levi Waldron working on mapping issues on this page to the NCBI taxonomy.
Pages in category "Pages with missing NCBI ID"
The following 200 pages are in this category, out of 201 total.
(previous page) (next page)S
- The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 5/Signature 1
- The tongue microbiome in healthy subjects and patients with intra-oral halitosis/Experiment 1/Signature 2
- Gut microbiome alterations in Alzheimer's disease/Experiment 1/Signature 1
- Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study/Experiment 2/Signature 2
- Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 2/Signature 1
- A taxonomic signature of obesity in a large study of American adults/Experiment 1/Signature 1
- A taxonomic signature of obesity in a large study of American adults/Experiment 1/Signature 2
- A taxonomic signature of obesity in a large study of American adults/Experiment 2/Signature 2
- A taxonomic signature of obesity in a large study of American adults/Experiment 3/Signature 2
- A taxonomic signature of obesity in a large study of American adults/Experiment 4/Signature 2
- A taxonomic signature of obesity in a large study of American adults/Experiment 5/Signature 2
- A taxonomic signature of obesity in a large study of American adults/Experiment 6/Signature 2
- Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients/Experiment 1/Signature 2
- The Perturbation of Infant Gut Microbiota Caused by Cesarean Delivery Is Partially Restored by Exclusive Breastfeeding/Experiment 1/Signature 1
- Mucosal microbiome dysbiosis in gastric carcinogenesis/Experiment 1/Signature 1
- Mucosal microbiome dysbiosis in gastric carcinogenesis/Experiment 3/Signature 1
- Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 2/Signature 1
- Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 3/Signature 1
- Air pollution during the winter period and respiratory tract microbial imbalance in a healthy young population in Northeastern China/Experiment 1/Signature 2
- Air pollution during the winter period and respiratory tract microbial imbalance in a healthy young population in Northeastern China/Experiment 2/Signature 2
- Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota/Experiment 1/Signature 2
- Altered fecal microbiota composition associated with food allergy in infants/Experiment 1/Signature 5
- Altered fecal microbiota composition associated with food allergy in infants/Experiment 3/Signature 2
- Altered fecal microbiota composition associated with food allergy in infants/Experiment 4/Signature 2
- Association of dietary fibre intake and gut microbiota in adults/Experiment 1/Signature 2
- Association of dietary fibre intake and gut microbiota in adults/Experiment 1/Signature 2
- Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease/Experiment 2/Signature 1
- Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia/Experiment 1/Signature 2
- Imbalance of Gut Streptococcus, Clostridium, and Akkermansia Determines the Natural Course of Atopic Dermatitis in Infant/Experiment 4/Signature 2
- Imbalance of Gut Streptococcus, Clostridium, and Akkermansia Determines the Natural Course of Atopic Dermatitis in Infant/Experiment 5/Signature 1
- Imbalance of Gut Streptococcus, Clostridium, and Akkermansia Determines the Natural Course of Atopic Dermatitis in Infant/Experiment 5/Signature 2
- Fecal microbiome signatures are different in food-allergic children compared to siblings and healthy children/Experiment 1/Signature 1
- Fecal microbiome signatures are different in food-allergic children compared to siblings and healthy children/Experiment 2/Signature 1
- Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls/Experiment 1/Signature 2
- Association Between Gut Microbiota and Helicobacter pylori-Related Gastric Lesions in a High-Risk Population of Gastric Cancer/Experiment 4/Signature 1
- Association Between Gut Microbiota and Helicobacter pylori-Related Gastric Lesions in a High-Risk Population of Gastric Cancer/Experiment 5/Signature 1
- Association Between Gut Microbiota and Helicobacter pylori-Related Gastric Lesions in a High-Risk Population of Gastric Cancer/Experiment 6/Signature 2
- Sex-specific impact of asthma during pregnancy on infant gut microbiota/Experiment 1/Signature 1
- Sex-specific impact of asthma during pregnancy on infant gut microbiota/Experiment 2/Signature 2
- The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 1/Signature 1
- The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 2/Signature 1
- The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 3/Signature 1
- The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis/Experiment 4/Signature 1
- The imbalance of gut microbiota and its correlation with plasma inflammatory cytokines in pemphigus vulgaris patients/Experiment 1/Signature 2
- Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions/Experiment 3/Signature 1
- Differences in Gut Microbiota Profiles between Autoimmune Pancreatitis and Chronic Pancreatitis/Experiment 1/Signature 1
- A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 1/Signature 1
- A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 2/Signature 1
- A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 3/Signature 1
- A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 4/Signature 1
- Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women/Experiment 1/Signature 1
- Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women/Experiment 1/Signature 2
- Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 4/Signature 1
- Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment/Experiment 4/Signature 2
- Cervical microbiome is altered in cervical intraepithelial neoplasia after loop electrosurgical excision procedure in china/Experiment 1/Signature 1
- Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection/Experiment 2/Signature 2
- Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia/Experiment 1/Signature 1
- Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia/Experiment 1/Signature 2
- Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia/Experiment 2/Signature 1
- Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia/Experiment 2/Signature 2
- Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia/Experiment 2/Signature 3
- Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia/Experiment 2/Signature 4
- Carious status and supragingival plaque microbiota in hemodialysis patients/Experiment 2/Signature 1
- Carious status and supragingival plaque microbiota in hemodialysis patients/Experiment 3/Signature 1
- Cervicovaginal microbiome and natural history of HPV in a longitudinal study/Experiment 1/Signature 1
- Cervicovaginal microbiome and natural history of HPV in a longitudinal study/Experiment 2/Signature 2
- Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women/Experiment 1/Signature 2
- Patients With LR-HPV Infection Have a Distinct Vaginal Microbiota in Comparison With Healthy Controls/Experiment 1/Signature 1
- Patients With LR-HPV Infection Have a Distinct Vaginal Microbiota in Comparison With Healthy Controls/Experiment 1/Signature 2
- Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota/Experiment 1/Signature 2
- Gut microbiota is critical for the induction of chemotherapy-induced pain/Experiment 1/Signature 2
- Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort/Experiment 1/Signature 1
- Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort/Experiment 1/Signature 2
- Chemotherapy-driven dysbiosis in the intestinal microbiome/Experiment 1/Signature 1
- Chemotherapy-driven dysbiosis in the intestinal microbiome/Experiment 1/Signature 2
- Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome/Experiment 1/Signature 1
- Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome/Experiment 2/Signature 1
- Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome/Experiment 3/Signature 1
- Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome/Experiment 3/Signature 2
- Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome/Experiment 5/Signature 1
- Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome/Experiment 5/Signature 2
- Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome/Experiment 6/Signature 1
- Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome/Experiment 6/Signature 2
- Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1/Signature 1
- Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1/Signature 2
- Exposure to concentrated ambient PM2.5 alters the composition of gut microbiota in a murine model/Experiment 1/Signature 1
- Exposure to concentrated ambient PM2.5 alters the composition of gut microbiota in a murine model/Experiment 1/Signature 2
- Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors/Experiment 1/Signature 2
- Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors/Experiment 2/Signature 1
- Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors/Experiment 2/Signature 2
- Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing/Experiment 2/Signature 2
- Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation/Experiment 1/Signature 2
- Effects of PM2.5 exposure during gestation on maternal gut microbiota and pregnancy outcomes/Experiment 1/Signature 1
- Effects of PM2.5 exposure during gestation on maternal gut microbiota and pregnancy outcomes/Experiment 1/Signature 2
- The gut microbiome of Mexican children affected by obesity/Experiment 1/Signature 1
- The gut microbiome of Mexican children affected by obesity/Experiment 1/Signature 2
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 1/Signature 1
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 1/Signature 2
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 3/Signature 1
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 3/Signature 2
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 4/Signature 1
- Sex-specific effects of PM2.5 maternal exposure on offspring's serum lipoproteins and gut microbiota/Experiment 2/Signature 1
- Sex-specific effects of PM2.5 maternal exposure on offspring's serum lipoproteins and gut microbiota/Experiment 3/Signature 1
- Sex-specific effects of PM2.5 maternal exposure on offspring's serum lipoproteins and gut microbiota/Experiment 5/Signature 1
- Sex-specific effects of PM2.5 maternal exposure on offspring's serum lipoproteins and gut microbiota/Experiment 5/Signature 2
- Sex-specific effects of PM2.5 maternal exposure on offspring's serum lipoproteins and gut microbiota/Experiment 6/Signature 1
- Sex-specific effects of PM2.5 maternal exposure on offspring's serum lipoproteins and gut microbiota/Experiment 6/Signature 2
- Sex-specific effects of PM2.5 maternal exposure on offspring's serum lipoproteins and gut microbiota/Experiment 7/Signature 2
- Effects of inhaled air pollution on markers of integrity, inflammation, and microbiota profiles of the intestines in Apolipoprotein E knockout mice/Experiment 1/Signature 2
- Effects of inhaled air pollution on markers of integrity, inflammation, and microbiota profiles of the intestines in Apolipoprotein E knockout mice/Experiment 2/Signature 1
- Effects of inhaled air pollution on markers of integrity, inflammation, and microbiota profiles of the intestines in Apolipoprotein E knockout mice/Experiment 2/Signature 2
- Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 1/Signature 1
- Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 2/Signature 2
- Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 3/Signature 1
- Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 3/Signature 2
- Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 4/Signature 1
- Effects of sex and chronic cigarette smoke exposure on the mouse cecal microbiome/Experiment 4/Signature 2
- Human Oral Buccal Microbiomes Are Associated with Farmworker Status and Azinphos-Methyl Agricultural Pesticide Exposure/Experiment 1/Signature 1
- Probiotics Ameliorate Colon Epithelial Injury Induced by Ambient Ultrafine Particles Exposure/Experiment 1/Signature 2
- Composition and metabolism of fecal microbiota from normal and overweight children are differentially affected by melibiose, raffinose and raffinose-derived fructans/Experiment 1/Signature 1
- Composition and metabolism of fecal microbiota from normal and overweight children are differentially affected by melibiose, raffinose and raffinose-derived fructans/Experiment 2/Signature 1
- Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects/Experiment 1/Signature 1
- Electronic Cigarette Aerosol Modulates the Oral Microbiome and Increases Risk of Infection/Experiment 1/Signature 2
- Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity/Experiment 1/Signature 1
- Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity/Experiment 2/Signature 1
- Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity/Experiment 2/Signature 2
- Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 2/Signature 1
- Oral microbiome and obesity in a large study of low-income and African-American populations/Experiment 2/Signature 2
- Alteration of the gut microbiome in first-episode drug-naïve and chronic medicated schizophrenia correlate with regional brain volumes/Experiment 1/Signature 2
- Alteration of the gut microbiome in first-episode drug-naïve and chronic medicated schizophrenia correlate with regional brain volumes/Experiment 2/Signature 2
- Signatures of Mucosal Microbiome in Oral Squamous Cell Carcinoma Identified Using a Random Forest Model/Experiment 1/Signature 2
- Analysis of the diversity of intestinal microbiome and its potential value as a biomarker in patients with schizophrenia: A cohort study/Experiment 1/Signature 1
- Variations in early gut microbiome are associated with childhood eczema/Experiment 7/Signature 1
- Maturation of the gut microbiome and risk of asthma in childhood/Experiment 2/Signature 2
- Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers/Experiment 1/Signature 1
- Patients With Reflux Esophagitis Possess a Possible Different Oral Microbiota Compared With Healthy Controls/Experiment 1/Signature 1
- Patients With Reflux Esophagitis Possess a Possible Different Oral Microbiota Compared With Healthy Controls/Experiment 1/Signature 2
- Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation/Experiment 1/Signature 2
- Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation/Experiment 1/Signature 3
- High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy/Experiment 1/Signature 2
- Fecal microbiome signatures of pancreatic cancer patients/Experiment 1/Signature 1
- Fecal microbiome signatures of pancreatic cancer patients/Experiment 1/Signature 2
- Fecal microbiome signatures of pancreatic cancer patients/Experiment 3/Signature 2
- Fecal microbiome signatures of pancreatic cancer patients/Experiment 4/Signature 1
- Alterations in Gastric Microbial Communities Are Associated with Risk of Gastric Cancer in a Korean Population: A Case-Control Study/Experiment 1/Signature 2
- Characterization of the Oral Microbiome of Medicated Type-2 Diabetes Patients/Experiment 1/Signature 1
- Characterization of the Oral Microbiome of Medicated Type-2 Diabetes Patients/Experiment 1/Signature 2
- The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes/Experiment 1/Signature 1
- Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients/Experiment 1/Signature 1
- Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 1/Signature 2
- Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 2/Signature 1
- Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery/Experiment 1/Signature 2
- Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing/Experiment 4/Signature 1
- Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19/Experiment 2/Signature 1
- Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19/Experiment 3/Signature 2
- Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 2/Signature 1
- Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study/Experiment 3/Signature 1
- Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome/Experiment 1/Signature 1
- Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome/Experiment 1/Signature 2
- Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome/Experiment 1/Signature 1
- Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome/Experiment 1/Signature 2
- Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18/Experiment 2/Signature 2
- The lower respiratory tract microbiome of critically ill patients with COVID-19/Experiment 1/Signature 2
- Effects of amoxicillin treatment on the salivary microbiota in children with acute otitis media/Experiment 2/Signature 1
- Comparative analysis of racial differences in breast tumor microbiome/Experiment 6/Signature 2
- Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis/Experiment 1/Signature 2
- Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis/Experiment 2/Signature 2
- Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis/Experiment 1/Signature 1
- An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis/Experiment 1/Signature 1
- An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis/Experiment 1/Signature 2
- Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study/Experiment 1/Signature 1
- Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study/Experiment 1/Signature 2
- Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health/Experiment 1/Signature 1
- Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health/Experiment 1/Signature 2
- The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function/Experiment 1/Signature 1
- Gut Microbial Composition and Function Are Altered in Patients with Early Rheumatoid Arthritis/Experiment 1/Signature 1
- Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis/Experiment 1/Signature 1
- Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function/Experiment 3/Signature 2
- The Association Between Smoking and Gut Microbiome in Bangladesh/Experiment 1/Signature 1
- The Association Between Smoking and Gut Microbiome in Bangladesh/Experiment 1/Signature 3
- Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers/Experiment 1/Signature 1
- Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults/Experiment 1/Signature 1
- Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults/Experiment 1/Signature 2
- Twice-daily application of HIV microbicides alter the vaginal microbiota/Experiment 1/Signature 1
- Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models/Experiment 1/Signature 2
- Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer/Experiment 1/Signature 1
- Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer/Experiment 1/Signature 2
- Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer/Experiment 1/Signature 1
- Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk/Experiment 1/Signature 2
- Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage/Experiment 1/Signature 1
- Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage/Experiment 1/Signature 2
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 2/Signature 1
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 2/Signature 2
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 3/Signature 2
- Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients/Experiment 1/Signature 2
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients/Experiment 1/Signature 1
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 6/Signature 1
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 6/Signature 2
- Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 2/Signature 1
- Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 3/Signature 1
